Skip to main content

Table 2 Number of patients for functional improvement by parental assessment according to randomization (before vs after) and time of mPBMC infusion (T1 vs T7)

From: Neuroregenerative potential of intravenous G-CSF and autologous peripheral blood stem cells in children with cerebral palsy: a randomized, double-blind, cross-over study

  Before randomization After randomization T1 T7 p*
Placebo mPBMC p +
Cognitive function 19 31 23 0.09 8 11 0.59
Motor function 3 0 2 0.15 0 0
Cognitive + motor function 5 14 16 0.65 13 14 0.83
No interval change 20 2 6 0.13 1 0 0.28
  1. mPBMC mobilized peripheral blood mononuclear cell; T1 and T7 refer to a group who received mPBMC at 1 and 7 months of study, respectively
  2. + p indicates statistical significances of items between placebo and mPBMC groups
  3. *p indicates statistical significances of items between before T1 and T7 groups
\